Best of February: Top 5 Insights In Clinical Supply Chain & Logistics

#1 Donating Surplus Clinical Trial Supplies Is Sustainability’s “Low-Hanging Fruit”

ClinOps professionals know all too well the waste that occurs with leftover trial kits that are destroyed at the end of the trial. Explore donation as a way to give those kits a second life.

#2 The Future Of Drug Storage & Distribution

In this roundtable discussion, learn the best strategies to anticipate and mitigate disruptions, and how future innovations and trends will continue to shape the logistics industry.

#3 When In The Product’s Life Cycle Does Continuous Manufacturing Make Sense?

This overview article takes a look at each product development stage for bio/pharmaceuticals to illuminate when continuous manufacturing can satisfy important business drivers.

#4 My Worst Nightmare In Randomization And Trial Supply Management: Accidental Unblinding

Learn how collaborative efforts from study managers, supply managers, biostatisticians, designers, and clinicians can better protect the blind in clinical trials and prevent accidental unblinding.

#5 Vendor/Supplier Management To Maintain A Drug’s Safety Profile In End-To-End Supply Chain Planning

FDA 21 CFR 211 requires vendor qualification as a part of the validation process and EU GxP requirements expect robust vendor management, and we expect regulators to issue firmer guidance sooner rather than later. Don't let your pharma/biotech fall short.